The future of melanoma and surgical oncology | 52 min

(0 review)
2272
students
0
Free

This presentation was recorded at A/Prof Alexander van Akkooi’s inaugural Australian lecture where he discusses his vision and aims for the future of melanoma...

Free

Critical questions for a melanoma pathologist | 36 min

(0 review)
2338
students
0
Free

The role of pathologist in the diagnosis and treatment of melanoma is pivotal to optimal patient care. With so many disciplines relying on the...

Free

Toxicity management in melanoma | 45 min

(0 review)
2454
students
0
Free

Cancer drugs have rapidly evolved in the last decade. Alongside the significant benefits are new toxicity profiles that clinicians need to be aware of...

Free

Update on the adjuvant treatment of melanoma in 2021 | 13 min

(0 review)
2567
students
0
Free

In this presentation, A/Prof Andrew Haydon reviews the efficacy data from 6 large-scale Phase III studies that are looking at the use of modern...

Free

Staging melanoma and bulky palpable Stage III melanoma – is surgery necessary? | 10 min

(0 review)
2567
students
0
Free

In this presentation, A/Prof Sydney Ch’ng discovers the current recommendations for sentinel node biopsy and the implications of high-risk Stage II melanoma trial findings....

Free

Management of in-transit melanoma in the time of active systemic therapy | 11 min

(0 review)
2567
students
0
Free

With up to 14% of patients developing in-transit disease and biologically diverse pathobiological behaviour is observed, in-transit disease is a significant clinical burden. In...

Free

Melanoma vs the double-edged sword | 47 min

(1 review)
2575
students
1
Free

Immune checkpoint inhibitors have revolutionised care for patients with advanced melanoma, with around half of patients with unresectable metastatic melanoma living to five years...

Free

Recent advances in the diagnosis and treatment of melanoma | 69 mins

(0 review)
2643
students
0
Free

In this presentation given at the Yale School of Medicine Dermatology Grand Rounds, world-leading melanoma pathologist, Prof Richard Scolyer AO, discusses: • MIA’s goals...

Free

The evolving paradigm shift in melanoma | 45 min

(1 review)
2789
students
1
Free

The field of melanoma has experienced a paradigm shift in recent years, with advancements in both diagnosis and management driving improved patient outcomes. Through...

Free